This paper (2022) explores the influence of macrodosing and microdosing on various clinical, social and cultural perspectives. The influence of microdosing is relatively unexplored in a formal context. Still, informal accounts propose that microdosing plays an important role as a therapeutic intervention and a cognitive enhancement tool.
Abstract of Macrodosing to microdosing with psychedelics
“To date, the clinical and scientific literature has best documented the effects of classical psychedelics, such as lysergic acid diethylamide (LSD), psilocybin, and dimethyltryptamine (DMT), in typical quantities most often associated with macrodosing. More recently, however, microdosing with psychedelics has emerged as a social trend and nascent therapeutic intervention. This variation in psychedelic practice refers to repeat, intermittent ingestion of less-than-macrodose amounts that do not cause the effects associated with full-blown “trips”. Microdosing paves the road to incorporating psychedelic drugs into a daily routine while maintaining, or even improving, cognitive and mental function. Unlike macrodosing with psychedelics, the influence of microdosing remains mostly unexplored. And yet, despite the paucity of formal studies, many informal accounts propose that microdosing plays an important role as both a therapeutic intervention (e.g., in mental disorders) and enhancement tool (e.g., recreationally—to boost creativity, improve cognition, and drive personal growth). In response to this relatively new practice, we provide an integrative synthesis of the clinical, social, and cultural dimensions of microdosing. We describe some of the overarching context that explains why this practice is increasingly in vogue, unpack potential benefits and risks, and comment on sociocultural implications. In addition, this article considers the effects that macro- and microdoses have on behavior and psychopathology in light of their dosage characteristics and contexts of use.”
Authors: Ayse Kaypak & Amir Raz
Summary of Macrodosing to microdosing with psychedelics
Psychedelic substances produce mind-altering experiences that may have therapeutic and recreational value. They mainly work through 5-HT2A receptor agonism, affecting perception, mood, and thought.
Microdosing has emerged as a modern practice with illegal substances, with great differences in substance, dose, frequency, and duration.
Microdosing is the frequent use of psychedelic substances in low doses, with many individuals reporting benefits in creativity and productivity. However, there is sparse scientific support from controlled studies.
Macrodoses
Find this paper
Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives
https://doi.org/10.1177%2F13634615221119386
Paywall | Google Scholar | Backup | 🕊
Cite this paper (APA)
Kaypak, A. C., & Raz, A. (2022). Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives. Transcultural psychiatry, 59(5), 665-674.
Study details
Topics studied
Microdosing
Study characteristics
Theory Building
Participants
0
Humans